Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Coronavirus disease 2019 (COVID-19) is a viral infection caused by SARS-CoV-2 that
induces a generalized inflammatory state. Organokines (adipokines, osteokines, myokines …

Abstract SARS-CoV-2 infection-induced hyper-inflammation links to the acute lung injury
and COVID-19 severity. Identifying the primary mediators that initiate the uncontrolled …

Hypertension, diabetes mellitus, and coronary artery disease are common comorbidities and
dangerous factors for infection and serious COVID-19. Polymorphisms in genes associated …

Coronavirus disease 2019 (COVID-19) has become a new public health crisis threatening
the world. Dysregulated immune responses are the most striking pathophysiological …

COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together
with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with …

Following an acute COVID-19 infection, a large number of patients experience persisting
symptoms for more than four weeks, a condition now classified as Long-COVID syndrome …

Environmental toxicants have been shown to promote the epigenetic transgenerational
inheritance of disease through exposure specific epigenetic alterations in the germline. The …

The current Coronavirus disease 2019 (COVID-19) pandemic has become a global
challenge. Managing a large number of acutely ill patients in a short time, whilst reducing …

Previous studies suggested that patients with comorbidities including cancer had a higher
risk of mortality or developing more severe forms of COVID-19. The interaction of cancer and …